YolTech Therapeutics to Participate in 2024 Cell & Gene Meeting on the Mediterranean
SHANGHAI, March 27, 2024 /PRNewswire/ -- YolTech Therapeutics, a trailblazing biopharmaceutical company specializing in gene editing, is delighted to announce its participation in 2024 Cell & Gene Meeting on the Mediterranean.
- SHANGHAI, March 27, 2024 /PRNewswire/ -- YolTech Therapeutics, a trailblazing biopharmaceutical company specializing in gene editing, is delighted to announce its participation in 2024 Cell & Gene Meeting on the Mediterranean.
- The Cell & Gene Meeting on the Mediterranean stands as the premier conference uniting the ATMP (Advanced Therapy Medicinal Products) community from Europe and beyond.
- Join YolTech at 2024 Cell & Gene Meeting on the Mediterranean to explore the forefront of gene editing and witness firsthand the transformative potential it holds for the future of medicine.
- For media inquiries or to schedule a meeting with YolTech Therapeutics' representatives at the event, please contact: